VERVE 2021: The Xeltis Hemodialysis Access Graft

Published: 22 Dec 2021

  • Views:

    Views Icon 30
  • Likes:

    Heart Icon 1

In this video interview from VERVE 2021, Professor Frans Moll (University Medical Center Utrecht, Utrecht, NL) discusses the  Xeltis Hemodialysis Access Graft, a new generation AV graft utilising endogenous tissue restoration. Prof Moll outlines the pre-clinical and clinical evidence supporting the use of this stent and discusses the first in human aXess study.

Discussion Points:
1. The Xeltis Hemodialysis Access Graft
2. Previous Research
3. Study Design and Patient Population
4. Next Steps

Recorded Remotely from Utrecht, 2021.

Interviewer: Jordan Rance

Videography: Dan Brent